Literature DB >> 33711687

Establishment of novel common marmoset embryonic stem cell lines under various conditions.

Keiko Kishimoto1, Akiko Shimada2, Haruka Shinohara1, Tsukasa Takahashi1, Yuko Yamada3, Yuichiro Higuchi4, Nao Yoneda4, Hiroshi Suemizu4, Kenji Kawai5, Yoko Kurotaki3, Kisaburo Hanazawa6, Yasuhiro Takashima2, Erika Sasaki7.   

Abstract

Pluripotent stem cells (PSCs), embryonic stem cells (ESCs), and induced PSCs (iPSCs) are excellent tools for studying embryonic development in organisms and classified into naïve and primed states. ESC-derived germline chimera individuals can be produced by injecting naïve ESCs/iPSCs into preimplantation embryos, and conversion of primed human ESCs/iPSCs into a naïve state provides insights into epiblast cell features. Non-human ESCs/iPSCs are alternatives to human naïve ESCs/iPSCs, which elicit ethical issues. In this study, we used the common marmoset (Callithrix jacchus) as an animal model. Since 1996, 16 marmoset ESC lines have been established. Because most of these ESC lines are female and were derived >10 years ago, new ESCs, particularly male marmoset ESC lines, are needed. Here, we successfully established 17 novel marmoset ESC lines, including six male ESC lines from in vitro-fertilized (IVF) embryos and 12 ESC lines under feeder-free conditions. This report is the first to establish ESC lines using feeder-free conditions and IVF preimplantation blastocysts in marmosets, and these novel ESC lines could potentially facilitate future non-human primate ESC studies.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Common marmoset; Embryonic stem cell; Feeder-free conditions; Male karyotype

Year:  2021        PMID: 33711687     DOI: 10.1016/j.scr.2021.102252

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  3 in total

1.  Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells.

Authors:  Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; María Piñeiro-Ramil; Silvia Rodríguez-Fernández; Isidoro López-Baltar; Isaac Fuentes-Boquete; Francisco J Blanco; Silvia Díaz-Prado
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-03       Impact factor: 6.698

Review 2.  Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies.

Authors:  Ignacio Rodriguez-Polo; Rüdiger Behr
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

3.  Pluripotent stem cells related to embryonic disc exhibit common self-renewal requirements in diverse livestock species.

Authors:  Masaki Kinoshita; Toshihiro Kobayashi; Benjamin Planells; Doris Klisch; Daniel Spindlow; Hideki Masaki; Susanne Bornelöv; Giuliano Giuseppe Stirparo; Hitomi Matsunari; Ayuko Uchikura; Ismael Lamas-Toranzo; Jennifer Nichols; Hiromitsu Nakauchi; Hiroshi Nagashima; Ramiro Alberio; Austin Smith
Journal:  Development       Date:  2021-12-07       Impact factor: 6.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.